BAS
EW icon

Brown Advisory Securities’s Edwards Lifesciences EW Stock Holding History

Brown Advisory Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,537
Closed -$240K – 76
2022
Q2 		$240K Sell
2,537
-1,922
-43% -$199K 0.23% 108
2022
Q1 		$523K Sell
4,459
-2,750
-38% -$309K 0.31% 78
2021
Q4 		$935K Sell
7,209
-3,664
-34% -$427K 0.4% 56
2021
Q3 		$1.23M Buy
10,873
+2,799
+35% +$319K 0.36% 64
2021
Q2 		$836K Buy
8,074
+607
+8% +$57.2K 0.13% 108
2021
Q1 		$625K Sell
7,467
-2,313
-24% -$196K 0.11% 127
2020
Q4 		$892K Buy
9,780
+1,379
+16% +$114K 0.15% 94
2020
Q3 		$671K Buy
8,401
+469
+6% +$36.6K 0.14% 110
2020
Q2 		$565K Buy
7,932
+126
+2% +$8.95K 0.12% 125
2020
Q1 		$507K Buy
7,806
+3,126
+67% +$225K 0.13% 128
2019
Q4 		$364K Sell
4,680
-240
-5% -$18.7K 0.09% 169
2019
Q3 		$360K Sell
4,920
-3,450
-41% -$242K 0.1% 164
2019
Q2 		$516K Buy
8,370
+537
+7% +$32.5K 0.14% 141
2019
Q1 		$499K Sell
7,833
-6,306
-45% -$360K 0.12% 159
2018
Q4 		$704K Sell
14,139
-1,395
-9% -$70.6K 0.13% 152
2018
Q3 		$901K Sell
15,534
-1,587
-9% -$77.6K 0.14% 144
2018
Q2 		$832K Buy
17,121
+2,460
+17% +$115K 0.14% 150
2018
Q1 		$684K Buy
14,661
+798
+6% +$34.7K 0.13% 162
2017
Q4 		$519K Buy
13,863
+354
+3% +$13K 0.1% 200
2017
Q3 		$494K Hold
13,509
– – 0.11% 187
2017
Q2 		$532K Buy
13,509
+2,400
+22% +$87.6K 0.12% 175
2017
Q1 		$350K Buy
11,109
+822
+8% +$25.7K 0.09% 218
2016
Q4 		$319K Buy
10,287
+5,211
+103% +$169K 0.09% 219
2016
Q3 		$203K Buy
+5,076
New +$191K 0.06% 266
2016
Q1 		– Sell
-8,424
Closed -$222K – 308
2015
Q4 		$222K Buy
+8,424
New +$219K 0.08% 232
2015
Q2 		– Sell
-8,640
Closed -$205K – 329
2015
Q1 		$205K Buy
+8,640
New +$194K 0.07% 267

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Securities's EW Position: Q3 2022 in Review

Brown Advisory Securities sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 2,537 shares — an estimated $240K sold.

Brown Advisory Securities first reported a position in EW in Q1 2015 and held it in 26 quarters. The position peaked at $1.23M in Q3 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Brown Advisory Securities reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Brown Advisory Securities sold 2,537 Edwards Lifesciences shares in Q3 2022, an estimated $240K.
  • Brown Advisory Securities first reported a position in Edwards Lifesciences in Q1 2015 and held it in 26 quarters.
  • Brown Advisory Securities's Edwards Lifesciences position peaked at $1.23M in Q3 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Brown Advisory Securities's 13F filing for Q3 2022, filed 14 Nov 2022.